Auszug
Herr K., damals Student der Betriebswissenschaft, erlebte mit 23 Jahren die erste Manifestation einer schizophrenen Psychose. Im Vordergrund standen eine deutliche Wahnstimmung sowie akustische und haptisch-taktile Halluzinationen. Herr K. wurde in eine psychiatrische Klinik aufgenommen und mit einem Atypika erfolgreich behandelt. Zuerst konnte Herr K. sein Studium erfolgreich fortführen, sodass er eigenverantwortlich die neuroleptische Therapie beendete. Vor dem Examen während der Prüfungsvorbereitung kam es zu einer zweiten psychotischen Episode mit ähnlicher Symptomatik und zu einer erneuten Einweisung in eine psychiatrische Klinik. Die Wiederansetzung des gleichen Atypikas führte zu einer partiellen Remission, wobei Wahn und Halluzination völlig verschwanden, die kognitive Leistungsfähigkeit sich jedoch nur eingeschränkt verbesserte. Mit größter Mühe konnte er sein Studium beenden, aber über Jahre keine Stellung finden. Zur mangelnden psychischen Belastbarkeit gesellte sich bald eine zunehmende Antriebsarmut. Herr K. zog sich allmählich von allen Freunden und seiner Familie zurück. Nach einer erneuten kurzen Exazerbation der psychotischen Symptomatik lebt Herr K., mittlerweile 33 Jahre alt, in einer betreuten Wohngruppe.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Andreasen NC (1982) Negative symptoms in schizophrenia. Arch Gen Psychiaty 39: 784–788
Andreasen NC (1983) Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa
Andreasen NC (1984) Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa
Baare WF, Hulshoff Pol HE, Hijman R, Mali WP, Viergever MA, Kahn RS (1999) Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol Psychiatry 45: 1597–1605
Bell MD, Mishara AL (2006) Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments. Schizophr Res 81: 17–27
Berman I, Viegner B, Merson A et al. (1997) Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr Res 25: 1–10
Bozikas VP, Kosmidis MH, Kioperlidou K, Karavatos A (2004) Relationship between psychopathology and cognitive functioning in schizophrenia. Compr Psychiatry 45: 392–400
Brazo P, Delamillieure P, Morello R et al. (2005) Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms. Psychiatry Res 133: 45–55
Brébion G, Smith MJ, Amador X et al. (1997) Clinical correlates of memory in schizophrenia: differential links between depression, positive and negative symptoms, and two types of memory impairment. Am J Psychiatry 154: 1538–1543
Brébion G, Amador X, Smith M et al. (2000) Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia. Neuropsychiatry Neuropsychol Behav Neurol 13: 177–183
Brébion G, Gorman JM, Malaspina D et al. (2001) Clinical and cognitive factors associated with verbal memory task performance in patients with schizophrenia. Am J Psychiatry 158: 758–764
Carpenter WT Jr, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145: 578–583
Crow T (1980) Molecular pathology of schizophrenia: more than one disease process? Brit Med J 80: 66–68
Ertugrul A, Ulug B (2002) The influence of neurocognitive deficits and symptoms on disability in schizophrenia. Acta Psychiatr Scand 105: 196–201
Gladsjo JA, McAdams LA, Palmer BW et al. (2004) A sixfactor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity. Schizophr Bull 30: 739–754
Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153: 321–330
Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the „right stuff“? Schizophr Bull 26: 119–136
Harvey PD, Howanitz E, Parrella M et al. (1998) Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry 155: 1080–1086
Hawkins KA, Hoffman RE, Quinlan DM et al. (1997) Cognition, negative symptoms, and diagnosis: a comparison of schizophrenic, bipolar, and control samples. J Neuropsychiatry Clin Neurosci 9: 81–89
Höse A (2000) Hirnstrukturelle Defizite. In: Volz HP, Kasper S, Möller HJ, Sachs G, Höse A (Hrsg) Die Rolle der Kognition in der Therapie schizophrener Störungen. Deutscher Universitätsverlag, Wiesbaden, S 91–133
Hughes C, Kumari V, Soni W et al. (2003) Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res 59: 137–146
Johnson-Selfridge M, Zalewski C (2001) Moderator variables of executive functioning in schizophrenia: metaanalytic findings. Schizophr Bull 27: 305–316
Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261–276
Klingberg S, Wittorf A, Wiedemann G (2006) Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions? Eur Arch Psychiatry Clin Neurosci 256: 532–540
Kohler C, Gur RC, Swanson CL et al. (1998) Depression in schizophrenia: I. Association with neuropsychological deficits. Biol Psychiatry 43: 165–172
Lucas S, Fitzgerald D, Redoblado-Hodge MA et al. (2004) Neuropsychological correlates of symptom profiles in first episode schizophrenia. Schizophr Res 71: 323–330
Milev P, Ho BC, Arndt S, Andreasen NC (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162: 495–506
Möller HJ (2000) Folge der Kognitionsstörung. In: Volz H-P, Kasper S, Möller H-J, Sachs G, Höse A (Hrsg) Die Rolle der Kognition in der Therapie schizophrener Störungen. Deutscher Universitätsverlag, Wiesbaden, S 145–172
Möser C, Krieg JC, Zihl J, Lautenbacher S (2006) Attention and memory deficits in schizophrenia: the role of symptoms of depression. Cogn Behav Neurol 19: 150–156
Niendam TA, Bearden CE, Johnson JK et al. (2006) Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res 84: 100–111
Nieuwenstein MR, Aleman A, de Haan EH (2001) Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. J Psychiatr Res 35: 119–125
Penades R, Gasto C, Boget T et al. (2001) Deficit in schizophrenia: the relationship between negative symptoms and neurocognition. Compr Psychiatry 42: 64–69
Roth RM, Flashman LA, Saykin AJ, McAllister TW, Vidaver R (2004) Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits. Am J Psychiatry 161: 157–159
Sanfilipo M, Lafargue T, Rusinek H et al. (2000) Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch Gen Psychiatry 57: 471–480
Sigmundsson T, Suckling J, Maier M et al. (2001) Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 158: 234–243
Tandon R, DeQuardo JR, Taylor SF et al. (2000) Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophr Res 45: 191–201
Tollefson GD, Sanger TM, Lu Y, Thieme ME (1998) Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry 55: 250–258
Turetsky B, Cowell PE, Gur RC et al. (1995) Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. Arch Gen Psychiatry 52: 1061–1070
Velligan DI, Mahurin RK, Diamond PL et al. (1997) The functional significance of symptomatology and cognitive function in schizophrenia. Schizophr Res 25: 21–31
Villalta-Gil V, Vilaplana M, Ochoa S et al. NEDENA Group (2006) Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients? Schizophr Res 87: 246–253
Voruganti LN, Heslegrave RJ, Awad AG (1997) Neurocognitive correlates of positive and negative syndromes in schizophrenia. Can J Psychiatry 42: 1066–1071
Wible CG, Anderson J, Shenton ME et al. (2001) Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study. Psychiatry Res 108: 65–78
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Lautenbacher, S. (2008). Negativsymptomatik — Psychologie. In: Neuropsychologie der Schizophrenie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71147-6_42
Download citation
DOI: https://doi.org/10.1007/978-3-540-71147-6_42
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71146-9
Online ISBN: 978-3-540-71147-6
eBook Packages: Medicine (German Language)